Literature DB >> 20418580

[Methodological aspects in valuing loss of production and informal care in cost-of-illness studies].

Maria Michela Gianino1, Michele Petrinco, Alberto Ferrando, Mario Galzerano, Dario Gregori, Eva Pagano.   

Abstract

Estimating costs of illness in social terms requires the consideration of the loss of production costs due to absence from work. Costs related to informal care should also be counted. Costs due to the loss of production are valued through the human capital method and the frictional costs method. Opportunity cost and proxy good methods are utilized for the informal care. Our study highlights practical issues about the use of a variety of methods and points out their main limits.

Entities:  

Mesh:

Year:  2009        PMID: 20418580

Source DB:  PubMed          Journal:  Epidemiol Prev        ISSN: 1120-9763            Impact factor:   1.901


  3 in total

Review 1.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

2.  Cost-consequence analysis of influenza vaccination among the staff of a large teaching hospital in Rome, Italy: A pilot study.

Authors:  Vittoria Colamesta; Andrea Tamburrano; Andrea Barbara; Andrea Gentili; Daniele Ignazio La Milia; Filippo Berloco; Americo Cicchetti; Daniele Piacentini; Roberta Galluzzi; Sergio Riccardo Mastrodonato; Andrea Cambieri; Walter Ricciardi; Patrizia Laurenti
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

3.  Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis.

Authors:  Eleonora Riccio; Massimo Sabbatini; Ivana Capuano; Angela Maria Pellegrino; Luigi Annicchiarico Petruzzelli; Antonio Pisani
Journal:  BMC Nephrol       Date:  2020-02-22       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.